Recent MSK Discoveries & Advances

Recent MSK Discoveries & Advances

Share
Share

Memorial Sloan Kettering researchers are relentlessly exploring every aspect of cancer — from basic investigations of cells and molecules to clinical trials of new treatments and population-wide studies of the disease. While our core mission is to translate this knowledge into new strategies to control cancer, many of our investigators are also making scientific progress against other diseases and conditions.

Below are some examples of discoveries and advances that recently were made in our laboratories and clinics, and featured in our news stories.

and/or
377 News Items found
Feature
Molecular biologist John Petrini of the Sloan Kettering Institute.
Understanding the DNA-Damage “First Responders”: John Petrini at Work
Scientists know that cancer can result from mistakes in DNA repair. But understanding what controls the repair process itself has been a hard nut to crack.
Feature
Andrea Cercek, a medical oncologist in MSK’s Gastrointestinal Service, speaking to a patient.
MSK Expert Weighs In on New Study Showing Rising Rates of Colorectal Cancer in Young People
Learn more from Andrea Cercek about a new study showing that colorectal cancer rates are increasing in younger people.
In the Lab
CAR T cells attacking cancer
CRISPR Genome-Editing Tool Takes Cancer Immunotherapy to the Next Level
What do you get when you combine two of the hottest areas of biotechnology? A new paper from MSK researchers explains.
In the Lab
Histology images of stem cells and AML cells
Step by Step: Stem Cell Approach Provides New Models for Studying How Acute Myeloid Leukemia Progresses
A new laboratory tool will allow researchers to study the progression from normal cells to myelodysplastic syndromes to an aggressive type of leukemia.
In the Lab
Pancreatic beta cells
Connecting the Dots: Stem Cells Provide Valuable Tool for Linking Genes and Disease
Researchers are using pluripotent stem cells to create models of diabetes and pancreatic cancer.
In the Lab
Lymphedema can produce uncomfortable swelling in the arms or legs in the months and years following cancer treatment.
Could a Topical Cream Prevent Lymphedema? Study in Mice Suggests Yes
By blocking a source of inflammation in the skin, it may be possible to prevent or treat lymphedema, a common and debilitating cancer complication.
In the Lab
Pathology slide showing DCIS and invasive cancer
Forensic Techniques Enable Study of Individual Breast Cancer Cells from MSK’s Archives
Analysis of long-preserved single cells on pathology slides aims to provide new clues about the genes that make breast cancer more aggressive.
Feature
Barry Taylor
With MSK Leading the Way, Precision Medicine Links Lab Research to Patient Care
Therapies that target genetic alterations in tumors are showing promise for many cancer patients, but challenges in developing these new treatments remain.
Finding
Woman giving presentation at work
Study Highlights Workplace Difficulties Some Women Face During Cancer Treatment
Discover the role of the work environment in the life and career of an employee with cancer.
Feature
Blue sphere (stem cell) with green dots scattered around the surface
Stemming the Tide: A Promising Target for Treating Some Blood Cancers
Learn about a potential new strategy for treating people with blood cancers such as acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) that targets a protein on cancer stem cells.